Objective: Possible regenerative treatments for lumbar intervertebral disc degeneration (DD) are rapidly emerging. There is consensus that the patient that would benefit most has early-stage DD, with a predicted deterioration in the near future. To identify this patient, the aim of this study was to identify prognostic factors for progression of DD. Study design: Systematic review. Methods: A systematic search was performed on studies evaluating one or more prognostic factor(s) in the progression of DD. The criteria for inclusion were (a) patients diagnosed with DD on MRI, (b) progression of DD at follow-up, and (c) reporting of one or more prognostic factor(s) in progression of DD. Two authors independently assessed the methodological quality of the included studies. Due to heterogeneity in DD determinants and outcomes, only a best-evidence synthesis could be conducted.
| INTRODUCTION
Intervertebral disc degeneration (DD) is a complex disease involving structural degradation of the normal, healthy matrix of the intervertebral disc. This matrix disruption is radiologically visualized by loss of disc height, an inhomogeneous structure of the disc, and the loss of distinction between nucleus pulposus and annulus fibrosus, [1] [2] [3] [4] often resulting in physical complaints like low back pain and morning stiffness. [5] [6] [7] The exact pathophysiology of DD is not yet completely understood, but it often starts at a quite young age with an imbalance in the interplay of biomechanics, cell behavior, and extracellular matrix, ending up in a cascade of degeneration. 8 Many initiating factors have been identified that can push the intervertebral disc into the vicious cycle of degeneration, such as mechanical overloading by heavy physical workload or systemic inflammatory disorders like diabetes, [9] [10] [11] [12] [13] [14] but the factors that encourage this downward spiral are less addressed, nor is there an overview of these prognostic factors present in literature. A prognostic factor is a clinical or biological aspect that is objectively measurable and that provides information on the possible course of the condition in an untreated patient. 15 Insight in these prognostic factors in the progression of DD will help us to differentiate between the different spinal phenotypes: the multiple appearances of DD in which the genotype and environment of the patient have a different interaction. It will also provide patients with more targeted information about their prognosis, and will also streamline the crucial process of shared-decision making, as no clear clinical algorithm is present for diagnosing or treating DD.
Currently, most patients with symptomatic DD (ie, degenerative disc disease) are put to pain medication and physical therapy, with spinal fusion as final option in end-stage degeneration. [16] [17] [18] More recently, preclinical studies on intervertebral disc regeneration show promising results for restoring cell homeostasis in moderate DD, [19] [20] [21] [22] [23] with expected increase of in vivo testing of these therapies in patients. 24, 25 It seems trivial that end-stage degeneration is too late to interfere with regenerative therapies. Therefore, the patient most suited for regenerative therapies has early-stage DD, with a high chance of deterioration in the near future. Therefore, the aim of this study was to identify and evaluate prognostic clinical, environmental and imaging factors that are associated with outcome, relative to baseline (ie, progression of DD), by a systematic review of the literature.
| METHODS
A review protocol was developed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)-statement (www.prisma-statement.org). 26 
| Literature search and selection of studies
The search strategy was developed with the consultation of an experienced health sciences librarian. PubMed, Embase.com, and Clarivate Analytics/Web of Science Core Collection were searched from inception up to 4 June 2018 (by C.M.E.R. and J.C.F.K.). The following terms were used (including synonyms and closely related words) as index terms or free-text words: "intervertebral disc degeneration" and "epidemiologic studies" and "disease progression" or "prognosis". The full search strategies for all databases can be found in the File S1. Duplicate articles were excluded. Manuscripts in English or German were accepted. Two investigators (C.M.E.R. and S.S.A.F.) screened all titles and abstracts for relevance independently from each other, using Covidence, an online screening tool for reviews by the Cochrane Collaboration (www.covidence.org). The in-and exclusion criteria were set prior to screening. Full-text articles were included when (a) patients were diagnosed with DD on MRI at baseline, (b) progression of DD was measured at follow-up ≥1 year after baseline, and (c) one or more prognostic factors in progression of DD was evaluated. Reviews, metaanalyses, congress abstracts, animal studies, and case series were excluded. Then the references of included articles were checked for any possible additional articles. When there was no consensus on the inclusion of an article by both investigators, the full-text was screened again and debated until consensus was reached. A third person (KSE) was available in case no consensus could be reached.
| Data extraction
A data-extraction form was developed to obtain the following information: authors, year of publication, number of patients, gender, age, months of follow-up, imaging modality, definition of DD, definition of progression, and researched prognostic factors, including their measurement methods, and statistical analyses method(s).
| Quality assessment
The included studies were independently subjected to a quality assessment by two authors (C.R. and S.F.), based on criteria described by Hayden et al. 27 These criteria were developed to assess the methodological quality of prediction studies and include 13 items, distributed over six categories: (a) study participation, (b) study attrition, (c) measurement of prognostic factors, (d) adjustment for confounding, (e) measurement of outcomes, and (f) appropriateness of statistical analyses. When an item was sufficiently addressed, the category was scored as 1. Otherwise, 0 points were scored, so there was a maximum score of 13 points. A score of ≥9 was regarded as a highquality study, and studies with a score of <9 were considered as lowquality studies. The same approach of quality assessment has been applied in studies evaluating prognostic factors in knee and hip arthritis. 28, 29 In case of disagreement, points were discussed until consensus was reached. Cohen's kappa statistic for inter-observer agreement 30 was calculated using IBM SPSS Statistics for Macintosh, Version 25.0. Armonk, New York: IBM Corp.
| Best-evidence-synthesis
Correlation coefficients of prognostic factors were statistically pooled if there was sufficient clinical and statistical homogeneity regarding the definition of DD, progression of DD, study population, and measurement methods of outcomes. In the absence of statistical analysis (correlation or beta coefficients) and heterogeneity in definition, measurement methods, and study design, the strength of evidence for prognostic factors was assessed according to a best-evidence synthesis. This method was introduced by Bastick, based on recommendations by of the Cochrane back review group, 28, 31 and is considered to be the golden standard for conducting analyses in heterogenic studies. Prognostic factors were categorized as follows:
• 
| Studies included
The literature search generated a total of 4261 studies. After the removal of duplicates, we screened the titles and abstracts of 3165 studies. Of these, we identified a total of 16 studies that met our inclusion criteria (Figure 1 ). There was a large variation in sample size (range: 19-617), with a total of 2434 patients, and the mean age varied between 13.1 and 65.4 years old. There was a large variety in the determination of DD and progression, but all included studies used MRI as imaging modality both at baseline and during follow-up. Some studies assessed DD and progression based on Pfirrmann's method, [32] [33] [34] [35] [36] [37] others used the Schneiderman's classification 38 or the Pearce classification, 39 or they developed their own method of DD and progression determination. [40] [41] [42] [43] [44] [45] [46] [47] Study characteristics can be found in Table 1 .
| Methodological quality
The Cohen's kappa statistic for inter-observer agreement was 0.75, representing good agreement. 30 Of the 16 studies included, 12 studies had a score of 9 points or more and were classified as high quality.
Most methodological shortcomings concern lack of adequate blinding (item H and J). An overview is presented in Table 2 . methods and association with DD progression is presented in Tables 3   and 4 . Only 12 studies include or report a correlation analysis of the prognostic factor's association with DD progression. Due to the lack of studies with sufficient statistical analysis and due to large heterogeneity between studies in measurement methods, including a high variation in DD and progression definitions, statistical pooling of the results was not possible. Consequently, it was necessary to summarize each prognostic factor according to a best-evidence synthesis to determine the strength of association with DD progression.
| Identified prognostic factors

| Best-evidence synthesis
There was only strong evidence (consistent [>75%] findings in multiple (≥ 2) high-quality studies) found that disc herniation at baseline is associated with progression of DD at follow-up (Table 5 ). Both the heterogeneity between and the limited amount of the included studies resulted at best in limited evidence for most prognostic factors, thereby limiting the informative value of the best-evidence synthesis.
Limited evidence (findings in one high-quality study or consistent
[>75%] findings in ≥3 low-quality studies) was found that that heritability, genetic risk factors (ie, T-allele IL1A rs1800587 female), fast bowling, weight lifted at work, work schedule, lack of sports activities, number of degenerated discs, presence and change of Modic type I and radial tears were, to some extent, associated with progression.
There was also some inconclusive evidence (findings found in <3 lowquality studies) due to the low-quality of the corresponding studies that lumbar lordosis, endplate degeneration, Schmorl nodes and the field position played in American football during high school are associated with progression. Conflicting evidence (<75% of the studies reported consistent findings) for progression was found for overweight, resistance training, lifting weight, and annulus tears.
Strong evidence (consistent (>75%) findings in multiple (≥ 2) highquality studies) was found that age, gender, body weight, BMI, smoking, car driving, occupation, and recreational activities at leisure time are not associated with progression, and there was limited evidence (findings in one high-quality study or consistent (>75%) findings in ≥3 low-quality studies) that obesity, pregnancy, DM, hypertension, back injuries, working style, and disc level were not associated with progression. Inconclusive evidence (findings found in <3 low-quality studies) was found that American football playing career, sacral slope, scoliosis, and listhesis are not associated with progression. IL6 rs1800795 genotype G/C male was the only factor that was associated with no progression, but this can only be qualified as limited evidence as this factor was only studied in one high-quality study. The item for which there was interobserver disagreement. Kappa = 0.75. The criteria were as follows, with 1 point for "yes" and 0 points for "no"; these therapies. The aim of this systematic review was to identify the prognostic factors associated with progression of DD. Despite the differences between definitions and the heterogeneity in measured determinants between the studies, we provided an overview of 12 imaging and 23 clinical and environmental prognostic factors.
| DISCUSSION
Strong evidence was found that the presence of disc herniation is associated with progression of DD at the same level. Disc herniation increases the mechanical stresses to the intervertebral disc as the main shock absorber, the nucleus pulposus, is pushed through the annulus, making the disc prone for the cascade of degeneration. Three studies showed that disc herniation at baseline was associated with progression of DD at follow-up. In those studies, disc herniation was determined on MRI. Elfering et al (a high-quality study) report that the initial extent of disc herniation (ie, protrusion or extrusion) was a significant risk factor for progression. 39 In this study, patients with symptomatic disc herniation that required surgery were included, although it is unclear whether these patients were operated during the followup period. Nagashima et al. (ie, low-quality study) found that a disc herniation (ie, protrusion or extrusion) evaluated at baseline on MRI significantly related to decrease in signal intensity of the nucleus pulposus 2 years later in 29 high school American Football players (P = .018). 41 Although the authors do not mention it explicitly, it seems that their study population did not suffer from any symptoms at baseline, as the study subjects were recruited from high school American Football players. It is unknown whether the American Football players diagnosed with disc herniation were put to any therapy.
The study of Sharma et al found that disc herniation at the time of the initial MRI study was significantly related to nuclear degeneration at follow-up. 37 Due to the retrospective design of the study, in which they searched their radiology report database without consulting the corresponding patients, it is unclear whether the patients with disc herniation on MRI were put to any medical treatment. The indication for the MRI was the only information provided, with low back pain as the most common indication (53 out of 63 patients). 37 whether disc herniation is truly a causal factor of progression and even the initiation of DD, or that it is a consequence of the native, in this case presumably inferior, quality of the discs. 52, 53 Since none of the three studies reported whether patients with disc herniation received any medical treatment, it is also unknown whether this affected the course of degeneration.
The most surprising outcome of this study is probably that strong evidence was found that age, gender, body weight, BMI, smoking, car driving, the type of occupation (ie, working as a nurse or construction Positive association between prognostic factor and increased disk progression. c Negative association between prognostic factor and increased disk progression. show that heavy physical activity or work and smoking are key factors in the onset of DD. 11, [54] [55] [56] For smoking, however, there is one highquality study (out of five) that finds that smoking during follow-up to a greater reduction in disc height. 42 This is in contrast to a study by the same authors 2 years earlier, in which they found that smoking did not have any effect on the change in degeneration. 43 Liuke et al found that there were no statistically significant differences in the number of discs with decreased signal intensity at baseline and follow-up between construction carpenters, machine operators, and office workers. 40 These results seem to indicate that some clinical and environmental factors (eg, age, gender, body weight, and smoking) are not associated with progression of DD. Positive association between prognostic factor and increased disk progression. b No association/no relationship found between prognostic factor and disk degeneration progression.
Negative association between prognostic factor and increased disk progression. Limited evidence (findings in one high-quality study or consistent (>75%) findings in ≥3 low-quality studies) was found for one genetic marker (specifically: IL6 rs1800795 genotype G/C male) to have a protective effect on progression, although the authors note in their study that correction for multiple testing weakened the associations for IL6 polymorphisms in their study. 46 IL6 is involved as an important cytokine in inflammatory reactions and seems to be produced at the site of lumbar disc herniation. 57, 58 A polymorphism to this gene might therefore have a preventive effect on damage to the extracellular matrix. Since modern techniques to evaluate genetic risk factors are becoming more accessible, more of these protective factors are expected to be discovered.
T A B L E 5 Best-evidence synthesis of prognostic factors in the progression of DD
The results of the present study should be interpreted with some caution and may not be directly applicable to the individual patient, as we did not include any symptoms into our inclusion criteria, resulting in an asymptomatic study population in many of the included studies.
We also only included manuscripts published in English or German, and therefore might have missed some other prognostic factors. In addition, no studies were found that studied molecular biomarkers in relation to progression of DD. This is surprising, as biomarkers are subject of many studies in relation to DD, [59] [60] [61] [62] but are presumably related to the onset of DD and not progression, which is beyond the scope of this review. Second, there was a high heterogeneity between studies regarding the definition of DD and its progression, which made it impossible to pool data. We were also unable to perform a quantitative analysis of the included studies, and therefore it was not possible to study the interplay and relative contribution of each prognostic factors in the progression of DD. Third, the causal relation between DD and low back pain remains disputed. We did not study the relationship of DD to the clinical presentation of patients.
Although previous studies have demonstrated that degenerative disc disease is associated with low back pain, 63, 64 more research needs to be conducted to identify how progression of DD is related to clinical course. The identification of prognostic factors for progression is crucial to establish optimal follow-up strategies and timing for regenerative medicine. Fourth, in some studies, it appeared that the same patient population was used within different studies, such as the three papers of Farshad-Amacker et al. [32] [33] [34] Since we present an overview of all studies that describe prognostic factors in the progression of DD, we presented these studies as three separate studies, since the outcomes would not have been affected if the results were presented in just a single study. Finally, there was conflicting evidence for overweight, resistance training, lifting weight and annulus tears, and many factors have been addressed by only one study, resulting in a high number of prognostic factors with limited evidence.
This high number of conflicting and limited evidence and the heterogeneity between the studies indicates that the current definition of DD is not on-point and that the natural history of DD is unclear. This is also reflected by the mostly unclear definitions of progression.
In most studies, it was defined as an increase in the grade of the specific grading system that was used compared to baseline, without any further description. A clear description of the studied subjects often lacked and it was sometimes unknown whether the study population suffered from symptoms or was asymptomatic. In addition, the interobserver reliability scores are usually reliability scores by the designers of the grading systems and not by independent and representative observers for grading DD. The reported statistic values are often concise and the effect sizes small. Subsequently, it is hard to draw firm conclusions or recommendations for clinical practice based on the outcomes of this study as it is difficult to predict which patients will reach the final stages of DD earlier than others patients, and thus, which patients should be targeted with regenerative therapies. Future research using identical determinants and outcome parameters on these factors may give a better insight in their role in the cascade of degeneration. These future studies should include a high number of patients, such as a population screening, as rapid progression of DD is probably the result of a synergistic effect between several prognostic factors, and not just one. The outcome of those studies would not only add to the understanding of the pathophysiology of DD, but also sharpen the definition of DD and its natural history, and provide valuable information for spinal phenotyping and clinical decision making. We would then know what combination of patients' specific factors will encourage progression of DD, which will enable physicians to predict which patients with DD will most likely progress to severe degeneration. This directly contributes to personalized medicine and thus, will clarify which patients should be targeted with regenerative therapies.
| CONCLUSION
This review shows strong evidence that disc herniation is associated with progression in DD, while most clinical and environmental risk factors (eg, age, gender, body weight, and smoking) are not associated with progression. However, limited or conflicting evidence was found for most of the prognostic factors, due to diversity in determinants and outcome parameters between the included studies. This makes it difficult to predict any risk factors for the progression of DD and shows that the current definition of DD is not on-point and that the natural history of DD is unclear. Future studies on these factors are recommended in order to identify the target group of patients for regenerative therapies and to sharpen the definition and natural history of DD. Future studies should use uniform definitions and welldescribed and universal determinants, in order to avoid confusion and to facilitate clearer comparisons.
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